Investors

CORPORATE
OVERVIEW
SEC Filings

PURE Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing our proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented, stabilized ionic silver, and our initial products contain Silver Dihydrogen Citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent that is manufactured as a liquid and delivered in various concentrations. We currently manufacture and distribute SDC-based disinfecting and sanitizing products, which are registered by the United States Environmental Protection Agency (EPA), the United States Food and Drug Administration (FDA) and Health Canada. We also manufacture and sell SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. We believe our technology platform has potential application in a number of industries and we intend to focus our current resources on providing food safety solutions to the food industry.

Corporate Governance
Corporate Governance
Code of Business Conduct and Ethics
View
Corporate Governance Guidelines
View
Audit Committee Charter
View
Compensation Committee Charter
View
Inquiries about stock accounts, or change in name or address may be directed to PURE Bioscience's stock transfer agent:

Transfer Online, Inc.
Attn: Carolyn Hall,
512 SE Salmon St. Portland, OR 97214

(503) 227-2950carolyn@transferonline.com
Other investor inquires may be directed to:

Mark Elliott
VP of Finance PURE Bioscience, Inc.

(619) 596-8600melliott@purebio.com
Receive Report Materials Electronically

Shareholders may opt for the convenience of electronic shareholder materials. Subscribers receive messages containing links to the online annual report and proxy statement, and may vote their proxies online. Interested shareholders may sign up here.

SCIENTIFIC 
ADVISORY
BOARD
SCOTT HARRIS, PH..D., MPSH
Scientific Advisory Board

JScott Harris, Ph.D., MSPH was appointed to our Scientific Advisory Board in August 2020. Dr. Harris is the Associate Director of EHS Services in the Austin, Texas office of GDS Associates and an adjunct faculty member at the University of Texas at San Antonio, University of Utah and University of North…more

MARTIN WIEDMANN, PH.D.
Scientific Advisory Board

Martin Wiedmann, Ph.D. was appointed to our Scientific Advisory Board in December 2020. Dr. Wiedmann received a veterinary degree and a doctorate in Veterinary Medicine from the Ludwig-Maximilians University in Munich, and a Ph.D. in Food Science from Cornell University, where he… more